GLP-1 Dosing Safety and How Patients Can Avoid Mistakes
Glucagon-like peptide-1 (GLP-1) receptor agonists are medications prescribed for managing type 2 diabetes and, increasingly, for weight loss. These drugs, which include well-known brands like Ozempic, Mounjaro, Zepbound, and Wegovy, represent a significant advancement in treatment. However, their growing popularity has been accompanied by a sharp rise in dosing errors and safety concerns. Understanding GLP-1 […]
Combined Therapies for T2D Show Improved Cardiac Health
For many years, managing type 2 diabetes (T2D) felt like a single-minded pursuit: get the blood sugar down. While crucial, this approach overlooked a more dangerous threat. People with type 2 diabetes are far more likely to experience serious cardiovascular problems, like heart attacks and strokes. The focus is now shifting towards a more comprehensive […]
Side Effects of Farxiga: What Patients Should Know
Like all medications, Farxiga comes with some possible risk of side effects. Healthcare providers are aware of these potential negative effects and will have taken them into account when issuing a prescription to a specific patient, based on their professional judgment that the benefits that the product gives to their patient outweigh the possible risk. […]
Study shows that early use of tirzepatide for diabetes yields cardiac benefits
Early use of tirzepatide appears to improve blood sugar, weight, and several heart-related risk markers in people with recently diagnosed type 2 diabetes. Interim findings from the SURPASS-EARLY trial conducted by Eli Lilly showed that patients treated within four years of diagnosis achieved stronger glycemic control, greater weight loss, and broader metabolic improvements than those receiving […]
Wegovy pill vs Rybelsus: what’s the difference?
“Wegovy pill” is a term that’s gathering a lot of interest on social media platforms. It refers to a new FDA-approved oral semaglutide tablet doctors can prescribe for weight management. This gets attention because most people are aware of the tremendous changes that the introduction of GLP-1 medications such as Ozempic and Wegovy have made in […]
Diabetes management is the next frontier
Type 2 diabetes (T2D) is one of the most prevalent chronic conditions in the general U.S. population, ranking alongside hypertension (high blood pressure), high cholesterol, and arthritis as one of the four most common chronic diseases. At this point in time, diabetes cannot be completely cured. The four main components of the current approach that […]
Understanding Inheritance, Heredity and Heritability
When I was growing up, there used to be a running joke that was trotted out when we gathered around the table at family get-togethers. One of the younger cousins would speak up and say “I love this family, but the problem is, there’s too much heredity, and not enough inheritance!” In some way, this […]
Fighting Off the ‘Flu – and Beating It After It Strikes
Public health websites encourage people to get their annual influenza vaccine not later than October 31 to ensure immunity builds up before peak flu season, which usually ramps up in November and lasts through winter. There’s the cute slogan “Flu before Boo”, which means get vaccinated before Halloween. Getting the shot by this time provides […]
Could Tirzepatide be a “Cure” for Type 2 Diabetes?
Normoglycemia is a term that’s drawing a lot of attention in medical circles lately, not because it is new, but because suddenly it seems possible that people who have a medical condition that has always been considered “incurable” may be able to achieve the normal state, which is what normoglycemia is. The thing that’s drawing […]
Rethinking Alcohol and Health
For decades, moderate drinking was praised for heart and brain protection, but science is rewriting that story. It’s hard to put it more bluntly than the World Health Organization did in its statement in January 2023, which said “No level of alcohol consumption is safe for health.” Newer studies that are based on facts rather […]
